Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC372

Lónapegsómatrópín

  • Status:
    Veitt
  • Application date:
    28.4.2022
  • Application published:
    15.5.2022
  • Grant published:
    15.2.2024
  • Max expiry date:
    16.1.2037
  • Medicine name:
    Lonapegsomatropin Ascendis Pharma
  • Medicine for children:
    No

Timeline

Today
28.4.2022Application
15.5.2022Publication
15.2.2024Registration
16.1.2037Expires

Marketing license

  • IS authorization number:
    EU/1/21/1607/001-009
  • Date:
    1.2.2022
  • Foreign authorization number:
    EU/1/21/1607
  • Date:
    11.1.2022

Owner

  • Name:
    ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S
  • Address:
    Tuborg Boulevard 12, Hellerup DK

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 19.01.2024

Upload documents